Welcome to our dedicated page for Butterfly Network SEC filings (Ticker: BFLY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Butterfly Network, Inc. filings document the formal disclosures of a public digital health company built around Ultrasound-on-Chip devices, ultrasound software and AI. Recent 8-K reports furnish quarterly and annual results, business updates, material agreements, executive and director matters, and listing-status notices affecting securities issued in connection with its prior business combination with Longview Acquisition Corp.
Proxy materials describe annual meeting proposals, director elections, auditor ratification and executive-compensation votes. Other filings cover the company’s Class A common stock, public warrants, capital structure and governance, including the NYSE Form 25 record for removal of the warrants from listing and registration, while operating disclosures address point-of-care ultrasound and Butterfly Embedded licensing activity.
Butterfly Network, Inc. director Louise S. Phanstiel, through The Phanstiel Trust u/a/d 2/5/02, purchased 115,200 shares of Class A Common Stock on 2026-08-14 at a weighted average price of $8.6763 per share, with trade prices ranging from $8.49 to $8.865 per share.
After this transaction, indirect holdings via the trust total 300,461 shares, and a separate entry reports 390,952 shares held directly. The filing does not indicate use of a Rule 10b5-1 trading plan.
Hood River Capital Management LLC reports beneficial ownership of Butterfly Network Inc. common stock. The firm holds 13,190,130 shares, representing 5.61% of the outstanding common stock. Hood River has sole dispositive power over these shares but reports no voting power, either sole or shared.
Butterfly Network, Inc. insider Nicholas Caezza, Deputy General Counsel, reported a sale of 10,000 shares of Class A common stock on 2026-08-11 at $9.75 per share in an open market or private transaction. Following this sale, Caezza directly holds 300,307 shares of Class A common stock. The filing indicates the Rule 10b5-1 trading-plan checkbox was not selected.
Butterfly Network, Inc. director and President & CEO Joseph DeVivo reported selling 68,346 shares of Class A common stock on August 10, 2026 at a weighted average price of $10.009 per share. The sale was executed pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2025, and DeVivo reported holding 7,603,700 shares of Class A common stock directly following the transaction.
Butterfly Network, Inc. insider Nicholas M. Caezza filed a notice of proposed sale of 10,000 Class A shares of common stock through Fidelity Brokerage Services LLC. The shares, carrying an aggregate market value of approximately $97,500.00, may be sold on the NYSE beginning on 08/11/2026.
The 10,000 shares were acquired from the issuer as compensation via restricted stock vesting on 03/01/2025. Caezza also reports a prior sale within the past three months of 1,733 Class A shares on 06/02/2026 for total proceeds of $7,831.25.
Butterfly Network, Inc. reported that Dr. Erica Schwartz has resigned from its Board of Directors, effective automatically upon her confirmation as Director of the U.S. Centers for Disease Control and Prevention on August 5, 2026. The company states that her resignation does not result from any disagreement regarding operations, policies, or practices.
A press release dated August 11, 2026, attached as an exhibit, further notes that Dr. Schwartz had served on the Board since 2021 and stepped down in advance of assuming her new role at the CDC. Butterfly Network’s President, CEO and Chairman, Joseph DeVivo, is quoted recognizing her contributions and service to the company.
Butterfly Network insider Joseph M. Devivo filed notice of intent to sell 68,346 Class A shares of common stock, expected from restricted stock vesting on December 17, 2024. The shares are held at Fidelity Brokerage Services and are listed on the NYSE.
Butterfly Network, Inc. insider Dawn Carfora filed to sell common stock under Rule 144 through Merrill Lynch. The planned sale covers 8,770 shares of common stock, with an indicated market value of $85,511.74, on the NYSE. The filing notes that Butterfly Network had 244,858,246 shares outstanding as of this notice. The shares derive from restricted stock unit awards that vested on 02/16/2022 and 02/16/2023, each for 4,385 shares and granted under the issuer’s equity compensation plan. In the past three months, Carfora also sold 176,301 shares of common stock for proceeds of $1,644,606.95 on 06/29/2026.
Butterfly Network, Inc. received a Schedule 13G filing indicating that FMR LLC, an institutional investor, reported beneficial ownership of 28,952,296.89 shares of the company’s Class A common stock, representing 11.8% of the outstanding class. FMR LLC reports sole dispositive power over these shares and no shared voting or dispositive power.
Abigail P. Johnson is also listed as a reporting person with sole dispositive power over the same 28,952,296.89 shares, reflecting control through FMR LLC and its subsidiaries. One or more other persons may have rights to dividends or sale proceeds, but no other individual holder exceeds 5% of the Class A common stock.
Butterfly Network, Inc. executive Megan Carlson, CAO and SVP, Finance, sold 68,852 shares of Class A Common Stock on July 31, 2026 in an open-market or private transaction at a weighted average price of $7.863 per share, with prices ranging from $7.775 to $8.005. After this sale, she directly holds 425,889 shares, including 28,835 shares acquired under the company’s employee stock purchase plan on June 30, 2026.